Is the PRSS1 (protease serine 1) mutation autosomal dominant or recessive?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 17, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

PRSS1 Inheritance Pattern

PRSS1 mutations follow an autosomal dominant inheritance pattern with incomplete penetrance of approximately 80%. 1, 2

Genetic Mechanism

  • PRSS1 (cationic trypsinogen gene) mutations are inherited in an autosomal dominant manner, meaning only one mutated copy of the gene is sufficient to cause hereditary pancreatitis 1, 3

  • The penetrance is incomplete at approximately 80%, which means not all individuals who inherit the mutation will develop clinical disease 2

  • This is not a recessive condition—individuals with just one mutated allele can develop hereditary pancreatitis 1

Clinical Implications of Dominant Inheritance

  • Affected individuals have a 50% chance of passing the mutation to each offspring, consistent with autosomal dominant transmission 1

  • The disease typically presents in childhood, often before age 10, with recurrent acute pancreatitis episodes progressing to chronic pancreatitis 2

  • Carriers face approximately 40% lifetime risk of pancreatic cancer, with cumulative risks of 10% at age 50,18.7% at age 60, and 53.5% at age 75 1, 2

Common Disease-Causing Mutations

  • The most frequent PRSS1 mutations are R122H and N29I, which account for approximately 90% of mutation-positive hereditary pancreatitis cases 1, 4

  • Additional rare mutations include R122C, N29T, and A16V, all following the same autosomal dominant pattern 3, 2

  • The R122H mutation specifically disrupts the trypsin autolysis site, preventing normal trypsin deactivation and leading to pancreatic autodigestion 1

Surveillance Considerations

  • PRSS1 mutation carriers with longstanding chronic pancreatitis require pancreatic cancer surveillance starting at age 40 or 20 years after the first pancreatitis attack, whichever comes first 5, 6

  • Screening is particularly critical given the substantially elevated cancer risk compared to the general population 5

References

Research

Hereditary pancreatitis.

World journal of gastroenterology, 2003

Research

An overview of hereditary pancreatitis.

Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 2012

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Genetic Testing in Recurrent Pancreatitis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.